ConductScience.org, home

Paper16808554

Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk.

Motsko SP and 6 others. Drug Saf, 2006. Cited by 69 papers, by iCite.

Cite this record

ConductScience Library. Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk. Papers, record 16808554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16808554

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk.
PubMed
Journal
Drug Saf
PubMed
Year
2006
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
69
iCite
Relative citation ratio, by iCite
2.18
iCite
Revised in PubMed
2018-11-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Motsko SPStephen P
2Rascati KLKaren L
3Busti AJAnthony J
4Wilson JPJames P
5Barner JCJamie C
6Lawson KAKenneth A
7Worchel JJason

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Inflammatory Agents, Non-SteroidalMajor topic
Cardiovascular DiseasesMajor topic
Cyclooxygenase 2 InhibitorsMajor topic
LactonesMajor topic
PyrazolesMajor topic
SulfonamidesMajor topic
SulfonesMajor topic
Age Factors
Celecoxib
Cohort Studies
Etodolac
Female
Humans
Ibuprofen
Male
Middle Aged
Naproxen
Time Factors
United States
Veterans

Source PubMed

Download CSV of topics

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115530895Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDs.Atherosclerosis2004https://conductscience.org/library/papers/15530895PubMed
215809459The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study of elderly adults.Ann Intern Med2005https://conductscience.org/library/papers/15809459PubMed
315713943Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.N Engl J Med2005https://conductscience.org/library/papers/15713943PubMed
49018214Where do elderly veterans obtain care for acute myocardial infarction: Department of Veterans Affairs or Medicare?Health Serv Res1997https://conductscience.org/library/papers/9018214PubMed
510491245Positive predictive value of the diagnosis of acute myocardial infarction in an administrative database.J Gen Intern Med1999https://conductscience.org/library/papers/10491245PubMed
616524325Cardiovascular events associated with long-term use of celecoxib, rofecoxib and meloxicam in Taiwan: an observational study.Drug Saf2006https://conductscience.org/library/papers/16524325PubMed
710979111
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
JAMA2000https://conductscience.org/library/papers/10979111PubMed
815713945Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery.N Engl J Med2005https://conductscience.org/library/papers/15713945PubMed
915853444Incidence of thrombotic cardiovascular events in patients taking celecoxib compared with those taking rofecoxib: interim results from the New Zealand Intensive Medicines Monitoring Programme.Drug Saf2005https://conductscience.org/library/papers/15853444PubMed
1014668809COX-2 and beyond: Approaches to prostaglandin inhibition in human disease.Nat Rev Drug Discov2003https://conductscience.org/library/papers/14668809PubMed
1111435450Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs.J Clin Invest2001https://conductscience.org/library/papers/11435450PubMed
1211160644Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2.J Pharmacol Exp Ther2001https://conductscience.org/library/papers/11160644PubMed
1312086701Expression of COX-1 and COX-2 mRNAs in atherosclerotic plaques.Exp Gerontol2002https://conductscience.org/library/papers/12086701PubMed
1415582059Risk of cardiovascular events and rofecoxib: cumulative meta-analysis.Lancet2004https://conductscience.org/library/papers/15582059PubMed
1510952950Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis.Circulation2000https://conductscience.org/library/papers/10952950PubMed
1611696466Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib.Circulation2001https://conductscience.org/library/papers/11696466PubMed
1711304662Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients.Am J Ther2001https://conductscience.org/library/papers/11304662PubMed
1811717412A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin.Proc Natl Acad Sci U S A2001https://conductscience.org/library/papers/11717412PubMed
1916119973A comparison of reported gastrointestinal and thromboembolic events between rofecoxib and celecoxib using observational data.Drug Saf2005https://conductscience.org/library/papers/16119973PubMed
2015096449Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults.Circulation2004https://conductscience.org/library/papers/15096449PubMed

See all 39 referencesDownload CSV of references

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.

PMIDTitleJournalYearIn PapersSource
38505473Cardiovascular Safety of Celecoxib after Cardiac Surgery with Cardiopulmonary Bypass: A Retrospective Cohort Study.Ann Clin Epidemiol2021https://conductscience.org/library/papers/38505473PubMed
35958187Comparison of Absolute Expression and Turnover Number of COX-1 and COX-2 in Human and Rodent Cells and Tissues.J Inflamm Res2022https://conductscience.org/library/papers/35958187PubMed
33879221Effect of acupotomy in knee osteoarthritis patients: study protocol for a randomized controlled trial.Trials2021https://conductscience.org/library/papers/33879221PubMed
33145451Evaluation of efficacy and safety of a novel lipogel containing diclofenac: A randomized, placebo controlled, double-blind clinical trial in patients with signs and symptoms of osteoarthritis.Contemp Clin Trials Commun2020https://conductscience.org/library/papers/33145451PubMed
31831964An open-label, prospective, multicenter, clinical study to evaluate efficacy of Ayuartis capsules in patients suffering from osteoarthritis of the knee(s).Ayu2019https://conductscience.org/library/papers/31831964PubMed
28664355Using Multiple Pharmacovigilance Models Improves the Timeliness of Signal Detection in Simulated Prospective Surveillance.Drug Saf2017https://conductscience.org/library/papers/28664355PubMed
25884765Model-based prediction of the acute and long-term safety profile of naproxen in rats.Br J Pharmacol2015https://conductscience.org/library/papers/25884765PubMed
24748817Clinical trial data in support of changing guidelines in osteoarthritis treatment.J Pain Res2014https://conductscience.org/library/papers/24748817PubMed
24444047Evolving guidelines in the use of topical nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritis.BMC Musculoskelet Disord2014https://conductscience.org/library/papers/24444047PubMed
23204844Long-term tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities.Clin Interv Aging2012https://conductscience.org/library/papers/23204844PubMed
23179898COX-2 inhibitor and non-selective NSAID use in those at increased risk of NSAID-related adverse events: a retrospective database study.Drugs Aging2013https://conductscience.org/library/papers/23179898PubMed
22861669A pathway to improved prospective observational post-authorization safety studies.Drug Saf2012https://conductscience.org/library/papers/22861669PubMed
22257309Influence of the drug exposure definition on the assessment of the antipsychotic metabolic impact in patients initially treated with mood-stabilizers.Br J Clin Pharmacol2012https://conductscience.org/library/papers/22257309PubMed
22076115Topical nonsteroidal anti-inflammatory drugs for management of osteoarthritis in long-term care patients.Ther Clin Risk Manag2011https://conductscience.org/library/papers/22076115PubMed
21975789Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity.Cochrane Database Syst Rev2011https://conductscience.org/library/papers/21975789PubMed
21770475Topical therapies for osteoarthritis.Drugs2011https://conductscience.org/library/papers/21770475PubMed
21174485
Safety and efficacy of topical diclofenac sodium gel for knee osteoarthritis in elderly and younger patients: pooled data from three randomized, double-blind, parallel-group, placebo-controlled, multicentre trials.
Drugs Aging2011https://conductscience.org/library/papers/21174485PubMed
20883058Should nonsteroidal anti-inflammatory drugs (NSAIDs) be prescribed to the older adult?Drugs Aging2010https://conductscience.org/library/papers/20883058PubMed
20696045Role of COX-2 in cough reflex sensitivity to inhaled capsaicin in patients with sinobronchial syndrome.Cough2010https://conductscience.org/library/papers/20696045PubMed
20064249Correlation of pain relief with physical function in hand osteoarthritis: randomized controlled trial post hoc analysis.Arthritis Res Ther2010https://conductscience.org/library/papers/20064249PubMed

See all 25 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16808554

GET https://conductscience.org/api/papers/v1/16808554/references?page=2